These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 38356845)

  • 41. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
    Su L; Zhang M; Zhang W; Cai C; Hong J
    Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baseline Modified Glasgow Prognostic Score Associated with Survival in Metastatic Urothelial Carcinoma Treated with Immune Checkpoint Inhibitors.
    Brown JT; Liu Y; Shabto JM; Martini DJ; Ravindranathan D; Hitron EE; Russler GA; Caulfield S; Yantorni LB; Joshi SS; Kissick H; Ogan K; Harris WB; Carthon BC; Kucuk O; Master VA; Bilen MA
    Oncologist; 2021 May; 26(5):397-405. PubMed ID: 33634507
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of blood-based PD-L1 analysis in patients with non-small cell lung cancer undergoing immune checkpoint inhibitor therapy: a systematic review and meta-analysis.
    Cui Q; Li W; Wang D; Wang S; Yu J
    World J Surg Oncol; 2023 Oct; 21(1):318. PubMed ID: 37821941
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of handgrip strength and high-sensitivity modified Glasgow prognostic score predicts survival outcomes in patients with colon cancer.
    Shi Y; Sun Y; Shen X; Yang Z; Xu B; Bao C
    Front Nutr; 2024; 11():1421560. PubMed ID: 39010859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.
    Ishihara H; Kondo T; Omae K; Takagi T; Iizuka J; Kobayashi H; Tanabe K
    Target Oncol; 2016 Oct; 11(5):605-617. PubMed ID: 27023922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer.
    Fan H; Shao ZY; Xiao YY; Xie ZH; Chen W; Xie H; Qin GY; Zhao NQ
    J Cancer Res Clin Oncol; 2016 Jun; 142(6):1285-97. PubMed ID: 26864695
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Modified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapy.
    Xiao Y; Ren YK; Cheng HJ; Wang L; Luo SX
    Int J Clin Exp Pathol; 2015; 8(5):5273-81. PubMed ID: 26191228
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nutritional and inflammatory measures predict survival of patients with stage IV colorectal cancer.
    Takamizawa Y; Shida D; Boku N; Nakamura Y; Ahiko Y; Yoshida T; Tanabe T; Takashima A; Kanemitsu Y
    BMC Cancer; 2020 Nov; 20(1):1092. PubMed ID: 33176752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Role of the Modified Glasgow Prognostic Score (mGPS) as a Prognostic Factor in Metastatic Colorectal Cancer.
    Cotan H; Iaciu C; Nitipir C
    Cureus; 2024 Jul; 16(7):e64916. PubMed ID: 39156325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of circulating tumor cells in patients with pancreatic cancer: a meta-analysis.
    Han L; Chen W; Zhao Q
    Tumour Biol; 2014 Mar; 35(3):2473-80. PubMed ID: 24218336
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Combination chemotherapy with TAS-102 plus bevacizumab in salvage-line treatment of metastatic colorectal cancer: A single-center, retrospective study examining the prognostic value of the modified Glasgow Prognostic Score in salvage-line therapy of metastatic colorectal cancer.
    Matsuhashi N; Takahashi T; Fujii H; Suetsugu T; Fukada M; Iwata Y; Tokumaru Y; Imai T; Mori R; Tanahashi T; Matsui S; Imai H; Tanaka Y; Yamaguchi K; Futamura M; Yoshida K
    Mol Clin Oncol; 2019 Oct; 11(4):390-396. PubMed ID: 31475067
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sarcopenia and modified Glasgow Prognostic Score predict postsurgical outcomes in localized renal cell carcinoma.
    Higgins MI; Martini DJ; Patil DH; Nabavizadeh R; Steele S; Williams M; Joshi SS; Narayan VM; Sekhar A; Psutka SP; Ogan K; Bilen MA; Master VA
    Cancer; 2021 Jun; 127(12):1974-1983. PubMed ID: 33760232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inflammatory markers for predicting overall survival in gastric cancer patients: A systematic review and meta-analysis.
    Kim MR; Kim AS; Choi HI; Jung JH; Park JY; Ko HJ
    PLoS One; 2020; 15(7):e0236445. PubMed ID: 32716955
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modified Glasgow Prognostic Score 2 as a Prognostic Marker in Patients With Metastatic Urothelial Carcinoma.
    Nagai T; Naiki T; Isobe T; Sugiyama Y; Etani T; Iida K; Nozaki S; Noda Y; Shimizu N; Tasaki Y; Mimura Y; Banno R; Kubota H; Hamamoto S; Kawai N; Yasui T
    In Vivo; 2021; 35(5):2793-2800. PubMed ID: 34410970
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of systemic inflammatory markers in patients with ALK-positive non-small cell lung cancer treated with crizotinib.
    Olmez OF; Bilici A; Gursoy P; Cubukcu E; Sakin A; Korkmaz T; Cil I; Cakar B; Menekse S; Demir T; Acikgoz O; Hamdard J
    Pulmonology; 2023; 29(6):478-485. PubMed ID: 36564237
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do relevant markers of cancer stem cells CD133 and Nestin indicate a poor prognosis in glioma patients? A systematic review and meta-analysis.
    Wu B; Sun C; Feng F; Ge M; Xia L
    J Exp Clin Cancer Res; 2015 May; 34(1):44. PubMed ID: 25967234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modified glasgow prognostic score as a prognostic factor in gastriccancer patients: a systematic review and meta-analysis.
    Zhang X; Chen X; Wu T; Zhang Y; Yan K; Sun X
    Int J Clin Exp Med; 2015; 8(9):15222-9. PubMed ID: 26629007
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors.
    Kang D; Liu S; Yuan X; Liu S; Zhang Z; He Z; Yin X; Mao H
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18215-18240. PubMed ID: 38078963
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Association between preoperative C-reactive protein level and colorectal cancer survival: a meta-analysis.
    Woo HD; Kim K; Kim J
    Cancer Causes Control; 2015 Nov; 26(11):1661-70. PubMed ID: 26376895
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glasgow prognostic score as a prognostic factor in metastatic castration-resistant prostate cancer treated with docetaxel-based chemotherapy.
    Linton A; Pond G; Clarke S; Vardy J; Galsky M; Sonpavde G
    Clin Genitourin Cancer; 2013 Dec; 11(4):423-30. PubMed ID: 23816526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.